Advertisement

Topics

Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation

20:00 EDT 16 May 2018 | AAAS

(University of Pennsylvania School of Medicine) A targeted therapy that has shown its power in fighting ovarian cancer in women including those with BRCA1 and BRCA2 mutations may also help patients with aggressive pancreatic cancer who harbor these mutations and have few or no other treatment options.

Original Article: Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation

NEXT ARTICLE

More From BioPortfolio on "Ovarian cancer drug shows promise in pancreatic cancer patients with BRCA mutation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...